摘要
恶性脑肿瘤包括原发性脑肿瘤(例如,多形性胶质母细胞瘤)及转移,对于多数患者来说,其为具有侵略性和致命性的实体。目前的标准治疗方法,包括手术,放疗和全身化疗相结合的方法仅适度改善患者病情。针对这些微弱的生命,急需尽力寻找有效的治疗方案。然而,血脑屏障(BBB)和血肿瘤屏障(BTB)是药物输送至脑肿瘤部位的的障碍。为达到恶性脑肿瘤更好的治疗效果需要优化给药方式,这是得到普遍公认的。某些引起关注的给药方式,如使用外科手术或物理技术,以提高治疗药物在中枢神经系统的分布。本文将以下给药方式进行综述:动脉内给药,透过血脑屏障给药,鼻腔给药,增强对流给药和渗透泵给药,皮下植入聚合物和磁性微球,超声破坏血脑屏障给药。本文目的是综述血脑屏障(BBB)和血肿瘤屏障(BTB)的重要性,及阐述上述给药方式的现状和前景。
关键词: 血脑屏障,血脑屏障破坏,脑肿瘤,化疗,药物输送,多形性胶质母细胞瘤,靶向给药。
图形摘要
Current Cancer Drug Targets
Title:Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Volume: 15 Issue: 9
Author(s): Annie Drapeau and David Fortin
Affiliation:
关键词: 血脑屏障,血脑屏障破坏,脑肿瘤,化疗,药物输送,多形性胶质母细胞瘤,靶向给药。
摘要: Malignant brain tumors including primary brain tumors (e.g., glioblastoma multiforme) and metastases, are aggressive and lethal entities for the majority of affected patients. Current standard treatments involving combinations of surgery, radiotherapy and systemic chemotherapy offer only modest improvements in survival. Faced with dismal survival, great efforts are deployed to find interesting treatment alternatives. However, the blood-brain barrier (BBB) and the blood-tumor barrier (BTB) remain great obstacles to significant drug delivery to brain tumors. The need to optimize delivery strategies for better patient outcome in the treatment of malignant brain tumors is well acknowledged. Certain interesting strategies use surgical or physical techniques to enhance the distribution of therapeutic agents to the central nervous system. The following strategies will be discussed in this review: intra-arterial delivery, osmotic BBB disruption, intranasal delivery, convection-enhanced delivery and osmotic pumps, implanted polymers, magnetic microspheres and ultrasound BBB disruption. The purpose of this paper is to review the importance of the BBB and the BTB and to review the current status and future perspectives of these delivery procedures.
Export Options
About this article
Cite this article as:
Annie Drapeau and David Fortin , Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous, Current Cancer Drug Targets 2015; 15 (9) . https://dx.doi.org/10.2174/1568009615666150616123548
DOI https://dx.doi.org/10.2174/1568009615666150616123548 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology TNF-Alpha Antagonism in Severe Asthma?
Recent Patents on Inflammation & Allergy Drug Discovery Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?
Current Vascular Pharmacology Nasal Polyposis: An Overview of Differential Diagnosis and Treatment
Recent Patents on Inflammation & Allergy Drug Discovery Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Giant Cell Arteritis – A Series of Cases and Review of Literature
Current Rheumatology Reviews Methylglyoxal and Advanced Glycation Endproducts: New Therapeutic Horizons?
Recent Patents on Cardiovascular Drug Discovery Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review
Current Pharmaceutical Design Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches
Current Medicinal Chemistry Glucagon Like Peptide-1 and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem
Current Drug Targets Distribution Characteristics of ANA and ANCA in Patients with Hyperthyroidism
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial (Thematic Issue: The Thoracic Space: An Amazing Pandora’s Box!)
Current Respiratory Medicine Reviews The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets MMP Inhibitors in Cardiac Diseases: An Update
Recent Patents on Cardiovascular Drug Discovery Use and Safety of Calcium Channel Blockers in Obstetrics
Current Medicinal Chemistry New Method of Inhibition of Activity of Tumor Necrosis Factor Alpha In Patients with Psoriasis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets